AQTUAL NAMES GREGG C. FERGUS TO ITS BOARD OF DIRECTORS
HAYWARD, Calif., Dec. 19, 2023 /PRNewswire/ -- Aqtual, a precision medicine company with a novel cfDNA platform to aid in treatment decisions for chronic diseases and cancers through a simple blood test, announced today that Gregg C. Fergus has joined as a member of its board of directors.
- Gregg brings over 30 years of corporate, entrepreneurial, and venture capital experience working with category-defining companies in life sciences.
- Gregg was CEO of 4Catalyzer, where he launched groundbreaking companies, including Butterfly Network, Hyperfine, Quantum-Si, and AI Therapeutics.
- Prior to 4Catalyzer, Gregg was president and COO of Ion Torrent, which sold to Life Technologies and is now a division of Thermo Scientific.
- Gregg currently serves as executive chairman of the board at Ascertain.